Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: November 18, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug, Dietary Supplement
  • Participants: 16
  • Start Date: December 9, 2019
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 20
  • Start Date: January 21, 2019
Effect of Low-Fat Compared to Low-Carbohydrate Diet on Fasting Lipids and Metabolic Profile in Subjects With Multifactorial Chylomicronemia: A Randomized Crossover Study
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 2
  • Start Date: December 2015
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Other
  • Participants: 16
  • Start Date: June 27, 2014
Glybera Registry, Long-term Safety and Efficacy Follow-up in Lipoprotein Lipase Deficient (LPLD) Patients Treated With Alipogene Tiparvovec (GLYBERA®)
Showing 1-5 of 5